Salute e Benessere

New data on aprocitentan to be presented at the AHA Hypertension Scientific…

Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar AwardAllschwil, Switzerland – September 5, 2024Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, Idorsia's endothelin receptor antagonist, will be presented at the American Heart Association (AHA) Hypertension Scientific Sessions 2024, taking place in Chicago, Illinois, September 5–8, 2024. On March 19, 2024, aprocitentan was approved as TRYVIO™ in the US, with availability planned...
Nasdaq GlobeNewswire
05/09/2024

Boehringer Ingelheim announces plans to advance potential new treatment for…

Ingelheim, Germany and Basel, Switzerland, September 5, 2024 – Boehringer Ingelheim and CDR-Life today announce positive results from the Phase I evaluation of BI 771716 (Study Record | ClinicalTrials.gov), an investigational antibody fragment developed to preserve vision in people living with geographic atrophy (GA). BI 771716 met its primary safety endpoint following intravitreal administration of single and multiple doses. Preparation for the Phase II trial is now underway, with an...
Nasdaq GlobeNewswire
05/09/2024

BIZCLIK MEDIA LAUNCHES SEPTEMBER EDITION OF HEALTHCARE DIGITAL

Healthcare Digital Healthcare Digital This month's edition includes an extensive lead feature with leading experts and executives from Oklahoma Cancer Specialists & Research Institute on transforming operations with GE Healthcare. "The addition of the zero-footprint viewer is fantastic for sharing images with outside physicians and providers who mutually care for patients. We can share images without granting access to our system, which is significant for security" -Jennifer...
PR Newswire
05/09/2024

Surgical Robots Market to Surge from USD 11.1 Billion to USD 23.7 Billion by…

Browse in-depth TOC on "Surgical Robots Market" Browse in-depth TOC on "Surgical Robots Market" 355 - Tables59 - Figures319 - Pages Market Segmentation by Offering The surgical robots market is categorized into instruments & accessories, robotic systems, and services. In 2023, the instruments and accessories segment is projected to dominate the market. These components are essential for enhancing the functionality, precision, and flexibility of robotic surgical...
PR Newswire
05/09/2024

Maxima Grupė's First Half of 2024: Moderate Revenue Growth due to Lower Product…

In the first half of 2024, the consolidated revenue of the companies managed by MAXIMA GRUPĖ, UAB increased by 4.7% compared to the same period last year, reaching €3 billion . The most significant contributors to this growth were ongoing expansion in Poland and Bulgaria, as well as increased sales in Lithuania and Latvia. Like-for-like (LFL) retail sales revenues, calculated at a constant exchange rate, grew by 2.2%. The overall revenue growth of the Group in the first half of this...
Nasdaq GlobeNewswire
05/09/2024

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent…

The company previously announced it closed $42M in Series D financing, led by EQT Life Sciences and Sectoral Asset Management, with new investors British Patient Capital, Northern Gritstone and Aphelion. The funding is primarily intended to bolster commercialization efforts for Phagenyx® in the US and Europe. Phagenyx® is the first and only pharyngeal electrical stimulation (PES) therapy that directly treats neurogenic dysphagia (difficulty swallowing), which is most often caused by stroke. Each…
PR Newswire
05/09/2024

Roborock Unveils World-First Smart Home Cleaning Technologies, Redefining the…

Roborock Qrevo Curv and Qrevo Edge: Setting New Standards with Industry-First AdaptiLift Chassis and Revolutionary Dual Anti-Tangle System Roborock Qrevo Curv and Qrevo Edge: Setting New Standards with Industry-First AdaptiLift Chassis and Revolutionary Dual Anti-Tangle System Roborock Qrevo Curv and Qrevo Edge introduce an industry-first innovation, the AdaptiLift Chassis, which incorporate an independently adjustable three-wheel control (left and right main wheels, and...
PR Newswire
05/09/2024

Andrew MacGarvey & Conditor Capital launch Coronado Research to maximise the use…

Sachin Korantak of Conditor Capital led the investment process, adding Coronado Research to a portfolio already positioned in the pre-clinical space. Sachin Korantak of Conditor Capital led the investment process, adding Coronado Research to a portfolio already positioned in the pre-clinical space. Korantak commented, "Conditor are very impressed with the vision set out by the Coronado team. Andrew has a deep understanding of how data can be used to optimise clinical development and a...
PR Newswire
05/09/2024

Tier-One Canadian Life and Health Insurance Carrier Selects Sapiens Insurance…

Sapiens Insurance Platform will be instrumental in enabling a client-first approach from the first touch point during new business to continued service excellence and administration, including enhanced support for their distribution channels, simplifying the business rules for an easier and proactive engagement, and continued enhanced support for the customer throughout their life events. This will be further enabled through simplified product development and management capabilities, a…
PR Newswire
05/09/2024

First Doses of Bavarian Nordic's Mpox Vaccine Now Arriving in the Democratic…

Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now entering the DRC, the epicenter of the mpox outbreakMore than 250,000 doses to arrive over the next week, marking a crucial turning point in the combat against mpox in AfricaCOPENHAGEN, Denmark, September 5, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today that the first doses of its mpox vaccine, MVA-BN ®, also known as JYNNEOS ®, has arrived today in the Democratic Republic of...
Nasdaq GlobeNewswire
05/09/2024

BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory…

MAINZ, Germany, September 05, 2024– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the European Society for Molecular Oncology (“ESMO”) Congress 2024 in Barcelona, Spain from September 13-17, 2024. The oral and poster presentations will feature programs across BioNTech's clinical pipeline, including mRNA-based cancer vaccines, next-generation immunomodulators and targeted therapy...
Nasdaq GlobeNewswire
05/09/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per September 2, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,377,683 shares, corresponding to 4.99% (previously 5.12%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
05/09/2024

OKYO Pharma Announces Chairman Acquires Shares

LONDON and NEW YORK, Sept.05, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announced today that it has been notified that Panetta Partners Limited, an...
Nasdaq GlobeNewswire
05/09/2024

Tube Packaging Market worth $4.6 Billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Tube Packaging Market". Browse in-depth TOC on "Tube Packaging Market". 368 – Tables 55 – Figures 279 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128857249 "By Type, Laminated accounted for the second-largest market share in 2023." Laminated accounted for the largest share among different types in the Tube packaging market. Laminated tubes offer superior barrier protection as compared to...
PR Newswire
05/09/2024

Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment…

To learn more about Hansa Biopharma see the latest Corporate Presentation here. The latest investor presentation can be viewed here. To learn more about Hansa Biopharma see the latest Corporate Presentationhere. The latest investor presentation can be viewedhere. For more information: Evan Ballantyne,Chief Financial OfficerE: ir@hansabiopharma.com Stephanie Kenney, VP Global Corporate Affairs E: media@hansabiopharma.com About Hansa Biopharma Hansa...
PR Newswire
05/09/2024

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences…

TTP executes a variety of projects, ranging from revamps of existing plants to the realization of future plants. The company has a strategic footprint in Europe and maintains a network of 27 locations in Austria, Belgium, France, Germany, and Switzerland. In 2023, about 1,000 employees[1] generated sales of some €170 million. In the coming years, TTP intends to continue the strong profitable growth of recent years. TTP executes a variety of projects, ranging from revamps of existing plants to...
PR Newswire
05/09/2024

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN…

Following the first two successful implantations, Venus-Vitae SMART-ALIGN pivotal clinical trial will be progressively launched at around 20 centers in Europe, North America and China, enrolling a total of 150 patients. The trial data will be used to support registration applications in the EU, Canada, China and other territories. Following the first two successful implantations, Venus-Vitae SMART-ALIGN pivotal clinical trial will be progressively launched at around 20 centers inEurope,...
PR Newswire
05/09/2024

Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia &…

Commenting on the recent appointment, Elif said, "I have had the privilege of witnessing firsthand how Pfizer has evolved and transformed the medical industry for nearly three decades – almost my entire career. Additionally, I have seen how the company's leadership prioritizes diversity, equity, and inclusion, not only for the patients in the markets they serve but also for employees at all levels and regions. I am thrilled to embark on this new chapter with Pfizer and am particularly…
PR Newswire
05/09/2024

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

COPENHAGEN, Denmark, September 5, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 7,164,460 as a consequence of employees' exercise of warrants.The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others. The shares were subscribed for in cash at the following prices per share of nominally DKK 10: 447,869 shares at DKK 146.60, 7,039 shares at DKK 155...
Nasdaq GlobeNewswire
05/09/2024

Capecitabine Market to Reach $0.7 Billion, Globally, by 2033 at 5% CAGR: Allied…

Prime Determinants of Growth Prime Determinants of Growth The global capecitabine market is experiencing growth due to surge in prevalence of cancer. Cancer, a complex and multifaceted disease, has seen a notable increase in incidence rates across various demographics and geographic regions in recent years. According to Colorectal Cancer Alliance, it was reported that each year, about 150, 000 Americans are diagnosed with colorectal cancer. Factors such as aging population, lifestyle...
PR Newswire
05/09/2024

European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene…

Dr Jean-Philippe Combal, Co-Founder & Chief Executive Officer at Vivet Therapeutics, said: "Early diagnosis and treatment of CTX is crucial to halting disease progression. At present, existing standard of care treatments can only slow or stabilize leukodystrophy, with no cure available. Preclinical data supports VTX-806's potential as an alternative treatment option to stop, or reverse, disease progression over the long-term, or possibly even cure CTX patients. Receiving ODD from the EU…
PR Newswire
05/09/2024

Trading in GN Store Nord shares by board members, executives and associated…

Trading in GN Store Nord shares by board members, executives and associated personsGN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. Details of the person discharging managerial responsibilities/person closely associated NameSøren Jelert Reason for the...
Nasdaq GlobeNewswire
05/09/2024

Build-A-Bear Workshop Celebrates National Teddy Bear Day on 9 September with…

The 9 September celebration of National Teddy Bear Day has become an annual tradition for the well-known experiential retailer that has now sold upwards of 240 million furry friends worldwide and has a stated mission to "add a little more heart to life." In the spirit of that mission, and in honour of National Teddy Bear Day, the philanthropic arm of the company, Build-A-Bear Foundation, will be donating more than 10,000 teddy bears to kids in need. This effort is just one part of the…
PR Newswire
05/09/2024

Statement re Change of Corporate Adviser

DXS INTERNATIONAL PLC(AQSE: DXSP)Change of Adviser DXS International plc (AQSE: DXSP) ("DXS" or the "Company"), the digital clinical decision support company, is pleased to announce that it has appointed Hybridan LLP as its AQSE Corporate Adviser with immediate effect. Hybridan remains AQSE Corporate Broker to the Company. The Directors of DXS accept responsibility for the contents of this announcement.This announcement contains information which, prior to its disclosure…
Nasdaq GlobeNewswire
05/09/2024
Altri  Comunicati